Status:
COMPLETED
A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Influenza
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
This open-label randomized 2 arm study will determine the emergence of viral resistance in participants with seasonal influenza A infection treated with oseltamivir. Eligible participants less than or...
Eligibility Criteria
Inclusion
- positive rapid antigen test for influenza A
- onset of symptoms of influenza (fever, at least one respiratory symptom) \</=48 hours
Exclusion
- clinical suspicion of infection with a respiratory virus other than influenza
- suspicion of invasive bacterial infection
- evidence of poorly controlled underlying disease
- known immunosuppression
- known allergy to Oseltamivir
- women who are pregnant or planning to get pregnant during the study
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00949533
Start Date
August 1 2009
End Date
October 1 2010
Last Update
August 8 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Curitiba, Brazil, 80810-040
2
São Paulo, Brazil, 04025-002
3
São Paulo, Brazil, 05508-000